Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1959 1
1965 1
1966 1
1973 1
1978 4
1979 1
1980 1
1982 1
1983 2
1984 1
2010 1
2013 1
2014 5
2015 4
2016 5
2017 5
2018 6
2019 12
2020 30
2021 28
2022 17
2023 8
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: haggerty af. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).
Arend RC, Monk BJ, Shapira-Frommer R, Haggerty AF, Alvarez EA, Amit A, Alvarez Secord A, Muller C, Casado Herraez A, Herzog TJ, Tewari KS, Cohen JG, Huang M, Yachnin A, Holeman LL, Ledermann JA, Rachmilewitz Minei T, Buyse M, Fain Shmueli S, Lavi M, Harats D, Penson RT; OVAL/GOG-3018 Investigators. Arend RC, et al. Among authors: haggerty af. J Clin Oncol. 2024 Jan 10;42(2):170-179. doi: 10.1200/JCO.22.02915. Epub 2023 Oct 31. J Clin Oncol. 2024. PMID: 37906726 Clinical Trial.
Biomaterials for spinal cord repair.
Haggerty AE, Oudega M. Haggerty AE, et al. Neurosci Bull. 2013 Aug;29(4):445-59. doi: 10.1007/s12264-013-1362-7. Epub 2013 Jul 18. Neurosci Bull. 2013. PMID: 23864367 Free PMC article. Review.
Validation of a tablet-based assessment of auditory sensitivity for researchers.
Wiseman K, Slotkin J, Spratford M, Haggerty A, Heusinkvelt M, Weintraub S, Gershon R, McCreery R. Wiseman K, et al. Among authors: haggerty a. Behav Res Methods. 2023 Sep;55(6):2838-2852. doi: 10.3758/s13428-022-01933-1. Epub 2022 Aug 12. Behav Res Methods. 2023. PMID: 35962308 Free PMC article.
Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue.
Wright AA, Poort H, Tavormina A, Schmiege SJ, Matulonis UA, Campos SM, Liu JF, Slivjak ET, Gilmour AL, Salinger JM, Haggerty AF, Arch JJ. Wright AA, et al. Among authors: haggerty af. Gynecol Oncol. 2023 Oct;177:165-172. doi: 10.1016/j.ygyno.2023.08.020. Epub 2023 Sep 13. Gynecol Oncol. 2023. PMID: 37708581 Clinical Trial.
Lymphadenectomy for early-stage mucinous ovarian carcinoma.
Heyward QD, Nasioudis D, Cory L, Haggerty AF, Ko EM, Latif N. Heyward QD, et al. Among authors: haggerty af. Int J Gynecol Cancer. 2021 Jan;31(1):104-109. doi: 10.1136/ijgc-2020-001817. Epub 2020 Nov 26. Int J Gynecol Cancer. 2021. PMID: 33243777
119 results